Orthopedic Biomaterials Market Size, Share and Trend Analysis | Global | 2025-2031 | MedSuite | Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more

The global orthopedic biomaterials device market was valued at $7.3 billion in 2024 and is expected to grow at a CAGR of 4.0%, reaching $9.6 billion by 2031.

This market includes multiple key segments:

• Bone Graft Substitute Market (Allograft, Demineralized Bone Matrix (DBM), and Synthetic Bone Grafts)
• Orthopedic Growth Factor Market
• Orthopedic Cell Therapy Market (Bone Marrow Aspirate Concentrate, Platelet-Rich Plasma)
• Hyaluronic Acid (HA) Viscosupplementation Market (Single-, Two-, Three-, and Five-Injection Cycles)
• Orthopedic Cartilage Repair Market (Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, and Osteochondral Autografts)

Market Insights & Data Coverage

• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

Aging Population Driving Market Growth:

• The global population aged 60+ surpassed 1 billion in 2020 and is projected to reach 2.1 billion by 2050.
• This demographic shift is expected to increase the demand for bone grafts and orthopedic biomaterials, especially for spinal fusion procedures due to age-related osteoarthritis and degenerative disc disease.

Growing Incidence of Osteoarthritis & Degenerative Conditions:

• Higher rates of age-related diseases and rising obesity levels will drive demand for orthopedic biomaterials and restorative procedures.
• Increased spinal fusion procedures will significantly boost the market for bone graft substitutes.

Advancements in Cell Therapy & Cartilage Repair:

• Innovative therapies like platelet-rich plasma and bone marrow aspirate concentrates are expanding in regenerative medicine.
• New cartilage repair techniques are improving patient outcomes and reducing the need for total joint replacements.

Market Share Insights

Top Competitors in the Global Orthopedic Biomaterials Market (2024):

1 Medtronic

• Market leader in orthopedic biomaterials, particularly bone graft substitutes and orthopedic growth factors.
• The INFUSE™ product line is a dominant player in the orthopedic growth factor market.

2 DePuy Synthes (Johnson & Johnson)

• Second-largest market share, strong presence in bone graft substitutes and HA viscosupplementation.
• Distributes leading HA products MONOVISC® and ORTHOVISC®, manufactured by Anika Therapeutics.

3 Fidia

• Specializes in the HA viscosupplementation market with a five-injection product (HYALGAN®) and the first-ever two-injection product (Hymovis®) in the U.S.
• TRILURON® - A pre-filled HA sodium salt product for knee osteoarthritis treatment.
• The two-injection segment is experiencing rapid growth as lower-injection treatment trends gain traction.

Market Segmentation Summary

• Bone Graft Substitute Market
• Material Type: Allograft, Demineralized Bone Matrix, Synthetic Substitutes
• Orthopedic Growth Factor Market
• Indication Type: Cervical Disc Degeneration, Tibial Fracture, Spine, Ankle & Hindfoot Fusions
• Orthopedic Cell Therapy Market
• Material Type: Platelet-Rich Plasma, Bone Marrow Aspirate Concentrates
• Hyaluronic Acid (HA) Viscosupplementation Market
• Material Type: Single-Injection, Two-Injection, Three-Injection, Five-Injection Cycles
• Orthopedic Cartilage Repair Market
• Treatment Type: Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, Osteochondral Autografts

Global Research Scope

• Regions Covered:
• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
• Western Europe (Germany, France, U.K., Spain, Italy)
• Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
• Middle East (Saudi Arabia, UAE, Israel)
• Asia Pacific (China, Japan, India, South Korea, Australia)
• Africa (South Africa, Egypt, Nigeria, Kenya)
• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources:

• Primary Interviews with Industry Leaders
• Government Physician Data & Regulatory Data
• Hospital Private Data
• Import & Export Data
• Internal Database